← Back to Clinical Trials
Recruiting NCT03823547

NCT03823547 Future Optimal Research and Care Evaluation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03823547
Status Recruiting
Phase
Sponsor J.M. ten Berg
Condition Acute Coronary Syndrome
Study Type OBSERVATIONAL
Enrollment 99,999 participants
Start Date 2015-01-01
Primary Completion 2050-06-30

Trial Parameters

Condition Acute Coronary Syndrome
Sponsor J.M. ten Berg
Study Type OBSERVATIONAL
Phase N/A
Enrollment 99,999
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2015-01-01
Completion 2050-06-30

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Rationale: Acute coronary syndrome (ACS) is the leading cause of death worldwide. To improve cardiovascular care, research is needed. Current guidelines are mainly based on well controlled RCT's, though evaluation of the impact of such RCT's in the real world is missing. In order to evaluate the impact and to overcome certain limitations of RCT's, a more practical approach is required. In this sense the use of nonrandomized observational studies is an important tool for determining the effectiveness of a therapy in routine clinical practice. One way to gain insight in characteristics of patients presenting in daily clinical practice, is to simply register these characteristics in a prospective manner with adequate follow up. Objective: To create an ongoing registry for evaluation of clinical long-term impact of diagnostics, various treatments and devices used for ACS, for research and evaluation of quality of care and to evaluate and improve regional quality of care and cooperation between PCI and non-PCI centers.

Eligibility Criteria

Inclusion Criteria: * All patients presenting with ACS * Age ≥ 18 years Exclusion Criteria: * No oral or signed informed consent available.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology